Global Patent Index - EP 1980257 A1

EP 1980257 A1 20081015 - Compositions and uses of galectin antagonists

Title (en)

Compositions and uses of galectin antagonists

Title (de)

Zusammensetzungen und Verwendung von Galectin-Antagonisten

Title (fr)

Compositions et utilisations d'antagonistes de galectine

Publication

EP 1980257 A1 20081015 (EN)

Application

EP 08010897 A 20040407

Priority

  • EP 04759200 A 20040407
  • US 46100603 P 20030407
  • US 40872303 A 20030407
  • US 47456203 P 20030530

Abstract (en)

The present invention is directed to methods and compositions for augmenting treatment of cancers and other proliferative disorders. In particular embodiments, the invention combines the administration of an agent that inhibits the anti-apoptotic activity of galectin-3 (e.g., a "galectin-3 inhibitor") so as to potentiate the toxicity of a chemotherapeutic agent. In certain preferred embodiments, the conjoint therapies of the present invention can be used to improve the efficacy of those chemotherapeutic agents whose cytotoxicity is influenced by the status of an anti-apoptotic Bcl-2 protein for the treated cell. For instance, galectin-3 inhibitors can be administered in combination with a chemotherapeutic agent that interferes with DNA replication fidelity or cell-cycle progression of cells undergoing unwanted proliferation.

IPC 8 full level

A61K 31/00 (2006.01); A61K 31/70 (2006.01); A61K 31/732 (2006.01); A61K 45/06 (2006.01)

CPC (source: EP)

A61K 31/00 (2013.01); A61K 31/732 (2013.01); A61K 45/06 (2013.01); A61P 35/00 (2017.12); A61P 43/00 (2017.12)

Citation (applicant)

  • US 5834442 A 19981110 - RAZ AVRAHAM [US], et al
  • US 5895784 A 19990420 - RAZ AVRAHAM [US], et al
  • US 6274566 B1 20010814 - ELIAZ ISAAC [US], et al
  • US 6500807 B1 20021231 - PLATT DAVID [US], et al
  • WO 03000118 A2 20030103 - GLYCOGENESYS INC [US]
  • US 2448793 A 19930301
  • WO 02100343 A2 20021219 - MANDALMED INC [US], et al
  • WO 02057284 A1 20020725 - NILSSON ULF [SE], et al
  • US 5176996 A 19930105 - HOGAN MICHAEL E [US], et al
  • US 5264564 A 19931123 - MATTEUCCI MARK [US]
  • US 5256775 A 19931026 - FROEHLER BRIAN C [US]
  • WO 0177350 A2 20011018 - LARGE SCALE BIOLOGY CORP [US], et al
  • WO 9011364 A1 19901004 - UNIVERSITY PATENTS INC [US]
  • US 5093246 A 19920303 - CECH THOMAS R [US], et al
  • WO 8804300 A1 19880616 - UNIVERSITY PATENTS INC [US]
  • US 6110462 A 20000829 - BARBAS CARLOS F [US], et al
  • US 6680306 B2 20040120 - CHANG YAN [US], et al
  • US 2003100535 A1 20030529 - CHANG YAN [US], et al
  • US 2003004132 A1 20030102 - CHANG YAN [US], et al
  • LIN ET AL., ONCOGENE, vol. 21, 2002, pages 8001 - 10
  • XIA ET AL., SEMIN. RADIAT. ONCOL., vol. 12, 2002, pages 296 - 304
  • HOCKENBERY ET AL., NATURE, vol. 348, 1990, pages 334 - 336
  • BOISE ET AL., CELL, vol. 74, 1993, pages 597 - 608
  • GIBSON ET AL., ONCOGENE, vol. 13, 1996, pages 665 - 675
  • ZHOU ET AL., BLOOD, vol. 89, 1997, pages 630 - 643
  • LIN ET AL., J. IMNTUNOL, vol. 151, 1993, pages 1979 - 1988
  • LEFFLER ET AL., J BIOL. CHEM., vol. 261, 1986, pages 10119
  • VAN DER KROL ET AL., BIOTECHNIQUES, vol. 6, 1988, pages 958 - 976
  • STEIN ET AL., CANCER RES., vol. 48, 1988, pages 2659 - 2668
  • GRIBSKOV; DEVEREUX: "Sequence Analysis Primer", 1991, STOCKTON PRESS
  • HEIDENREICH ET AL., NUCLEIC ACIDS RES., vol. 25, 1997, pages 776 - 780
  • WILSON ET AL., J. MOL. RECOG., vol. 7, 1994, pages 89 - 98
  • CHEN ET AL., NUCLEIC ACIDS RES., vol. 23, 1995, pages 2661 - 2668
  • AIRSCHBEIN ET AL., ANTISENSE NUCLEIE ACID DRUG DEV., vol. 7, 1997, pages 55 - 61
  • PADDISON ET AL., J GENES DEV ., vol. 16, 2002, pages 948 - 58
  • MCCAFFREY ET AL., NATURE, vol. 418, 2002, pages 38 - 9
  • MCMANUS ET AL., RNA, vol. 8, 2002, pages 842 - 50
  • YU ET AL., PROC. NAT'L ACAD. SCT. USA, vol. 99, 2002, pages 6047 - 52
  • SARVER ET AL., SCIENCE, vol. 247, 1990, pages 1222 - 1225
  • HASELOFF; GERLAEH, NATURE, vol. 334, 1988, pages 585 - 591
  • ZAUG ET AL., SCIENCE, vol. 224, 1984, pages 574 - 578
  • ZAUG; CECH, SCIENCE, vol. 231, 1986, pages 470 - 475
  • ZANG ET AL., NATURE, vol. 324, 1986, pages 429 - 433
  • BEEN; CECH, CELL, vol. 47, 1986, pages 207 - 216
  • KLUIN-NELEMANS ET AL.: "A new non-Hodgkin's B-cell line (DoHH2) with a chromosomal translocation t(14;18)(q32;q21", LEUKEMIA, vol. 5, no. 3, March 1991 (1991-03-01), pages 221 - 4

Citation (search report)

Designated contracting state (EPC)

AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PL PT RO SE SI SK TR

Designated extension state (EPC)

AL HR LT LV MK

DOCDB simple family (publication)

WO 2004091634 A1 20041028; AU 2004229399 A1 20041028; AU 2004229399 B2 20100805; CA 2521649 A1 20041028; CA 2521649 C 20130528; DE 602004014485 D1 20080731; EP 1617849 A1 20060125; EP 1617849 B1 20080618; EP 1980257 A1 20081015; JP 2006522163 A 20060928

DOCDB simple family (application)

US 2004010675 W 20040407; AU 2004229399 A 20040407; CA 2521649 A 20040407; DE 602004014485 T 20040407; EP 04759200 A 20040407; EP 08010897 A 20040407; JP 2006509773 A 20040407